I-Tech AB ITECH.ST
ITECH.ST
I-Tech AB ONCO.ST
Oncopeptides AB (publ) SYNACT.ST
SynAct Pharma AB XSPRAY.ST
Xspray Pharma AB (publ) GENO.ST
Genovis AB (publ.) CRAD-B.ST
C-Rad AB (publ) IBT-B.ST
Infant Bacterial Therapeutics AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) CANTA.ST
Cantargia AB (publ) SEDANA.ST
Sedana Medical AB (publ)
I-Tech AB ONCO.ST
Oncopeptides AB (publ) SYNACT.ST
SynAct Pharma AB XSPRAY.ST
Xspray Pharma AB (publ) GENO.ST
Genovis AB (publ.) CRAD-B.ST
C-Rad AB (publ) IBT-B.ST
Infant Bacterial Therapeutics AB (publ) DMYD-B.ST
Diamyd Medical AB (publ) CANTA.ST
Cantargia AB (publ) SEDANA.ST
Sedana Medical AB (publ)
Performance
| Periode | ITECH.ST | ONCO.ST | SYNACT.ST | XSPRAY.ST | GENO.ST | CRAD-B.ST | IBT-B.ST | DMYD-B.ST | CANTA.ST | SEDANA.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -8.27 % | 160.91 % | 15.53 % | -27.81 % | 13.43 % | 12.69 % | 25.52 % | 41.24 % | 55.10 % | 50.48 % |
| YTD | 22.00 % | 225.32 % | 128.34 % | -40.11 % | -6.56 % | 12.50 % | 5.40 % | -37.16 % | 43.24 % | -31.36 % |
| 1Y | 48.18 % | 149.51 % | 140.16 % | -55.18 % | 1.79 % | -9.02 % | 73.85 % | -19.52 % | -20.68 % | -44.60 % |
| 3Y | 48.18 % | -41.79 % | -56.52 % | -54.57 % | -38.38 % | -5.13 % | 7.84 % | -18.35 % | -33.72 % | -51.13 % |
| 5Y | 4.87 % | -95.73 % | -53.99 % | -80.70 % | -25.85 % | -17.98 % | -59.07 % | -67.76 % | -95.65 % | -81.14 % |
| 10Y | 196.72 % | -83.22 % | 327.77 % | -16.08 % | 1 241.18 % | 85.28 % | 3.48 % | 76.36 % | -69.28 % | 110.42 % |
| From the beginning | 196.72 % | -83.22 % | 327.77 % | -16.08 % | -53.42 % | 133.77 % | 3.48 % | 226.44 % | -71.33 % | 110.42 % |